• RM576 Save up to RM288 with the Yearly Premium Plan (Limited Time Only)
  • RM480 Save up to RM240 with the Yearly Advanced Plan (Limited Time Only)
Subscribe Now
premium Subscription Plan
add free StockBiz
YouTube MS Production

Last Price Change Volume
KLSE Market Watch
Open: Day Range: Prev Close:


OTHERS UCREST BERHAD ("UCREST" OR THE "COMPANY") - IMEDIC OPTICS, AI FOR EYE DISEASE DIAGNOSIS

UCREST BERHAD

Type Announcement
Subject OTHERS
Description
UCREST BERHAD ("UCREST" OR THE "COMPANY")
- IMEDIC OPTICS, AI FOR EYE DISEASE DIAGNOSIS

The Board of Directors of the Company wishes to announce that UCrest has launched iMedic Optics™, the eye health screening and diagnosis platform using Artificial Intelligence ("AI") technology to process retinal images from the fundus camera. The product is launched concurrently in Asia and the US market.

iMedic Optics™ is the AI technology that can diagnose several eye diseases including Age-related Macular Degeneration (AMD), Glaucoma, Diabetic Retinopathy (DR) with more than 10 various eye conditions in seconds from the images of the retina uploaded from the fundus camera, up to 100% accuracy consistently with the patent pending proprietary methodology and algorithm as any false diagnosis may result in severe consequences.

The release of iMedic Optics is not expected to have a material effect on the earnings per share, net assets per share and gearing of the Company for the financial year ending 31 May 2025.

The announcement is dated 18 June 2024.






Announcement Info

Company Name UCREST BERHAD
Stock Name UCREST
Date Announced 18 Jun 2024
Category General Announcement for PLC
Reference Number GA1-13062024-00026



Close
New Feature
MS Academy
AI StockMaster. Beat The Market! Checking MS Signal
DETECT REAL-TIME STOCK MOVEMENT
X
(InvestorPro Plan Only)
Complimentary access on Premium Plan*
What is AI StockMaster?
Window Alert On-Screen Alert X
X